YF-VAX 4.74 [PFU]/.5mL
YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Sanofi Vaccines US Inc.
YF-VAX is a injection, powder, lyophilized, for suspension containing yellow fever virus strain 17d-204 live antigen at 4.74 [PFU]/.5mL, taken subcutaneous. Manufactured by Sanofi Vaccines US Inc..
Key Facts
- Brand Name
- YF-VAX
- Generic Name
- YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN
- NDC Code (Product)
49281-915- Manufacturer
- Sanofi Vaccines US Inc.
- Strength
- 4.74 [PFU]/.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103915
- Marketing Start
- 05/22/1953
Recall History
No Recall HistoryFrequently Asked Questions
What is YF-VAX used for?
YF-VAX contains YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN. It is a injection, powder, lyophilized, for suspension taken subcutaneous. Consult your doctor for specific uses.
Is YF-VAX a controlled substance?
YF-VAX is not classified as a controlled substance by the DEA.
What is the generic name for YF-VAX?
The generic name for YF-VAX is YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN. There are no other listed brand versions of YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN.
What is the NDC code for YF-VAX 4.74 [PFU]/.5mL?
The NDC (National Drug Code) for YF-VAX 4.74 [PFU]/.5mL is 49281-915, listed by Sanofi Vaccines US Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)